Medtronic PLC (MDT) Actualités

Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients

Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years...

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients

SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small...

Medtronic announces cash dividend for fourth quarter of fiscal year 2025

Medtronic announces cash dividend for fourth quarter of fiscal year 2025 PR Newswire GALWAY, Ireland, March 6...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with...

Form 8-K - Current report

Medtronic reports third quarter fiscal 2025 financial results

Medtronic reports third quarter fiscal 2025 financial results PR Newswire GALWAY, Ireland, Feb. 18, 2025...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Medtronic to announce financial results for its third quarter of fiscal year 2025

Medtronic to announce financial results for its third quarter of fiscal year 2025 PR Newswire GALWAY, Ireland...